1-247965840-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004491.2(OR2AK2):āc.464A>Gā(p.Asn155Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000145 in 1,613,408 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004491.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2AK2 | NM_001004491.2 | c.464A>G | p.Asn155Ser | missense_variant | 1/1 | ENST00000366480.5 | NP_001004491.2 | |
OR2L13 | NM_001304535.3 | c.-19+28456A>G | intron_variant | NP_001291464.1 | ||||
OR2L13 | NM_175911.5 | c.-144+28456A>G | intron_variant | NP_787107.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2AK2 | ENST00000366480.5 | c.464A>G | p.Asn155Ser | missense_variant | 1/1 | 6 | NM_001004491.2 | ENSP00000355436.4 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000160 AC: 40AN: 250334Hom.: 0 AF XY: 0.000163 AC XY: 22AN XY: 135230
GnomAD4 exome AF: 0.000151 AC: 220AN: 1461242Hom.: 1 Cov.: 34 AF XY: 0.000136 AC XY: 99AN XY: 726852
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 04, 2024 | The c.509A>G (p.N170S) alteration is located in exon 1 (coding exon 1) of the OR2AK2 gene. This alteration results from a A to G substitution at nucleotide position 509, causing the asparagine (N) at amino acid position 170 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at